Samsung Biologics Listed on Dow Jones Best-in-Class World Index for Fifth Consecutive Year

Samsung Biologics Listed on Dow Jones Best-in-Class World Index for Fifth Consecutive Year

Marks five consecutive years of inclusion, reflecting continued progress in ESG management and execution Recognition highlights proactive alignment with evolving expectations from global stakeholders INCHEON, South Korea, May 5, 2026 /PRNewswire/ --...

menu
menu